Why the study?
Malignant cardiac lymphoma is rare and commonly involves nodules on the right side of the heart, with diffuse extension into the left ventricle being unusual.
This case demonstrates that rare diffuse left ventricular involvement of cardiac malignant lymphoma can present as heart failure with severe left ventricular hypertrophy but only mild diastolic dysfunction, and can be effectively treated with Pola-R-CHP chemotherapy resulting in improved cardiac function.
Answers are grounded in this paper and cite their sources.
Consider lymphoma in unexplained LVH with diffuse enhancement; leaves open optimal biopsy thresholds in atypical cases.
Malignant cardiac lymphoma is rare and commonly involves nodules on the right side of the heart. We herein report a case of malignant cardiac lymphoma with diffuse extension into the left ventricle. The patient was a woman in her 60s who complained of dyspnea and malaise. Echocardiography revealed left ventricular hypertrophy (LVH), and magnetic resonance imaging revealed diffuse contrast enhancement on delayed contrast. Cardiac catheterization and a myocardial biopsy suggested heart failure due to cardiac malignant lymphoma, and diastolic dysfunction was mild despite LVH. The patient underwent chemotherapy, and her cardiac function improved and was maintained.
No takes yet. Share an insight, caveat, or question.
Terunuma et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: